Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: A retrospective, multicenter Polish Adult Leukemia Group study-Reference-Cited by-同舟云学术

Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: A retrospective, multicenter Polish Adult Leukemia Group study

Published:2015-09-21 Issue:10 Volume:90 Page:904-909
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Grosicki Sebastian¹,Holowiecki Jerzy²,Kuliczkowski Kazimierz³,Skotnicki Aleksander⁴,Hellmann Andrzej⁵,Kyrcz-Krzemien Slawomira⁶,Dmoszynska Anna⁷,Sułek Kazimierz⁸,Kloczko Janusz⁹,Jedrzejczak Wieslaw W.¹⁰,Warzocha Krzysztof¹¹,Zdziarska Barbara¹²,Wierzbowska Agnieszka¹³,Pluta Agnieszka¹³,Komarnicki Mieczyslaw¹⁴,Giebel Sebastian²

Affiliation:

1. Department of Cancer Prevention, School of Public Health; Medical University of Silesia; Katowice Poland

2. Department of Bone Marrow Transplantation, Branch Gliwice; Comprehensive Cancer Center M. Sklodowska-Curie Memorial Institute; Gliwice Poland

3. Department of Haematology, Hematopoietic Malignancies and BMT; Medical University; Wroclaw Poland

4. Department of Haematology, Collegium Medicum; Jagiellonian University; Cracow Poland

5. Department of Haematology and Transplantology; Medical University; Gdansk Poland

6. Department of Haematology and Bone Marrow Transplantation; Medical University of Silesia; Katowice Poland

7. Samodzielna Pracownia Transplantologii Klinicznej; Uniwersytet Medyczny; Lublin Poland

8. Military Medical Institute; Warsaw Poland

9. Department of Hematology; Medical University; Bialystok Poland

10. Department of Hematology, Oncology and Internal Medicine; Medical University; Warsaw Poland

11. Department of Haematology; Institute of Haematology and Transfusion Medicine; Warsaw Poland

12. Department of Internal Medicine and Haematology; SPSK Nr 1; Szczecin Poland

13. Department of Haematology, Copernicus Memorial Hospital; Medical University; Lodz Poland

14. Department of Hematology and Proliferative Diseases of The Hematopoietic Systems; Poznan University of Medical Sciences; Poznan Poland

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24113/fullpdf

Reference40 articles.

1. Cancer and Leukemia Group B (CALGB 8461): Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461);Byrd;Blood,2002

2. French Acute Myeloid Leukemia Intergroup; Groupe Ouest-Est des Leucemies Aigues Myeoblastiques; Leucemies Aigues Myeoblastiques de l'Enfant; Acute Leukemia French Association; Bordeaux-Grenoble-Marseille-Toulouse cooperative groups: Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): A survey of 110 cases from the French AML intergroup;Delaunay;Blood,2003

3. Prognostic factors in acute myelogenous leukemia;Estey;Leukemia,2001

4. Clinical importance of cytogenetics in acute myeloid leukaemia;Mrozek;Best Pract Res Clin Haematol,2001

5. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group study;Slovak;Blood,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia;eJHaem;2022-05-23

2. Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML;European Journal of Haematology;2019-02-13

3. Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: A National Population-Based Cohort Study;Biology of Blood and Marrow Transplantation;2018-02

4. Myeloid-derived suppressor cells as effectors of immune suppression in cancer;International Journal of Cancer;2016-07-12